Symbiotic use in mild preeclampsia pregnancy :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Synbiotic Supplementation tied to favourable pregnancy outcomes! Read to know

Pregnancy supplementation Pregnancy supplementation
Pregnancy supplementation Pregnancy supplementation

What's new?

Synbiotic supplements show promise in ameliorating preeclampsia indicators, benefiting both mothers and newborns.

The findings of a recent randomized controlled trial found that supplementation of synbiotics in pregnant women with mild pre-eclampsia (PE) was found to be safe and had significant positive effects on pregnancy outcomes, such as high blood pressure (BP) along with improved proteinuria and serum creatinine levels.

The study by Rouhina Movaghar et al. compared the effect of synbiotics and placebo on primary outcomes including blood pressure and pregnancy duration, alongside other pregnancy-related factors.

One hundred and twenty-eight pregnant women with mild PE and a gestational age of more than 24 weeks were included in this randomized, controlled, triple-blinded clinical study. These women were randomized to the intervention group (given one synbiotic capsule orally until labour) and the control or placebo group (given a placebo daily until labour). Preeclampsia was stratified into early (less than 34 weeks) or late (more than equal to 34 weeks) based on gestational age at diagnosis. The data gathered from different questionnaires and serum biochemical parameters were examined using SPSS software version 23.

Other than the history of vitamin D3 intake, there were no statistically significant differences in socio-demographic variables among the study groups. Compared to the placebo group, the women in the synbiotic group demonstrated considerably lower mean systolic blood pressure (BP) (adjusted mean difference, AMD: -13.54) and diastolic BP (AMD: -10.30). No significant associations were observed for outcomes other than noteworthy decreases in the rate of severe preeclampsia (p < 0.001), proteinuria (p = 0.044), and mean serum creatinine level (p = 0.005).

To ascertain the benefits of synbiotic supplementation for high-risk pregnancies, there is a need for further studies with larger samples, especially concerning higher doses and longer therapy durations, concluded Rouhina Movaghar.

Source:

BMC Women's Health

Article:

The effects of synbiotic supplementation on blood pressure and other maternal outcomes in pregnant mothers with mild preeclampsia: a triple-blinded randomized controlled trial

Authors:

Rouhina Movaghar et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: